Downstream purification continues to pressure the biopharmaceutical manufacturing industry from a capacity standpoint, with recent increases in upstream yield and titers overcoming the relatively slow ...
With the 2017 release of the Biomanufacturing Technology Roadmap published by BioPhorum Operations Group, 1 our industry projected a clear vision for the future of monoclonal antibody (mAb) production ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results